Your browser is no longer supported. Please, upgrade your browser.
Enzo Biochem, Inc.
Index- P/E30.74 EPS (ttm)0.11 Insider Own8.60% Shs Outstand48.47M Perf Week5.06%
Market Cap157.97M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float36.83M Perf Month4.73%
Income5.30M PEG- EPS next Q- Inst Own48.50% Short Float1.82% Perf Quarter0.30%
Sales115.60M P/S1.37 EPS this Y127.30% Inst Trans0.02% Short Ratio4.44 Perf Half Y6.07%
Book/sh1.38 P/B2.41 EPS next Y- ROA4.70% Target Price- Perf Year3.75%
Cash/sh0.76 P/C4.36 EPS next 5Y- ROE8.00% 52W Range2.61 - 4.85 Perf YTD3.43%
Dividend- P/FCF- EPS past 5Y-30.00% ROI-8.60% 52W High-31.55% Beta0.81
Dividend %- Quick Ratio2.20 Sales past 5Y2.80% Gross Margin45.80% 52W Low27.20% ATR0.16
Employees451 Current Ratio2.90 Sales Q/Q-7.70% Oper. Margin-7.50% RSI (14)56.08 Volatility4.35% 4.40%
OptionableYes Debt/Eq0.07 EPS Q/Q-866.70% Profit Margin4.50% Rel Volume1.03 Prev Close3.31
ShortableYes LT Debt/Eq0.07 EarningsDec 15 AMC Payout0.00% Avg Volume151.17K Price3.32
Recom- SMA204.25% SMA500.17% SMA2000.87% Volume182,228 Change0.30%
Oct-18-11Reiterated Rodman & Renshaw Mkt Outperform $7 → $5
Sep-23-09Initiated Rodman & Renshaw Mkt Outperform $14
Sep-13-07Initiated Lazard Capital Buy $19
Jan-14-22 09:38AM  
Jan-03-22 04:10PM  
Dec-15-21 04:05PM  
Dec-06-21 08:38PM  
Dec-02-21 04:05PM  
Nov-23-21 06:26AM  
Nov-09-21 10:18AM  
Oct-25-21 08:00AM  
Oct-21-21 08:38AM  
Oct-19-21 07:00AM  
Oct-18-21 08:17AM  
Oct-12-21 07:00AM  
Sep-28-21 08:00AM  
Sep-12-21 09:35AM  
Sep-02-21 04:05PM  
Jul-20-21 08:00AM  
Jul-14-21 02:32AM  
Jun-15-21 12:00PM  
Jun-09-21 04:05PM  
Jun-01-21 04:05PM  
May-15-21 04:24AM  
May-05-21 12:05PM  
Apr-21-21 08:00AM  
Mar-31-21 03:41AM  
Mar-17-21 04:15PM  
Mar-16-21 09:59AM  
Mar-15-21 04:05PM  
Mar-12-21 08:00AM  
Mar-04-21 08:00AM  
Mar-02-21 08:00AM  
Mar-01-21 04:05PM  
Feb-03-21 08:30AM  
Jan-30-21 03:37AM  
Jan-22-21 07:26PM  
Jan-20-21 08:14AM  
Jan-15-21 11:39AM  
Jan-05-21 01:27PM  
Jan-04-21 07:00AM  
Dec-31-20 07:30PM  
Dec-28-20 08:00AM  
Dec-24-20 02:06PM  
Dec-15-20 08:00AM  
Dec-10-20 07:53PM  
Dec-09-20 04:01PM  
Dec-02-20 08:00AM  
Dec-01-20 01:22AM  
Nov-25-20 08:00AM  
Nov-18-20 01:00PM  
Nov-17-20 08:00AM  
Nov-05-20 08:00AM  
Oct-27-20 08:00AM  
Oct-14-20 07:53AM  
Oct-13-20 04:01PM  
Oct-06-20 03:42PM  
Sep-15-20 09:29AM  
Sep-08-20 08:00AM  
Aug-03-20 03:15PM  
Jul-21-20 08:30AM  
Jul-17-20 01:56PM  
Jul-13-20 08:50AM  
Jun-30-20 01:15PM  
Jun-25-20 05:50PM  
Jun-23-20 08:30AM  
Jun-08-20 04:05PM  
Jun-03-20 04:05PM  
May-20-20 08:00AM  
May-12-20 08:00AM  
Apr-29-20 08:00AM  
Apr-23-20 08:00AM  
Mar-24-20 07:50AM  
Mar-20-20 06:00AM  
Mar-13-20 07:38PM  
Mar-09-20 02:44PM  
Mar-06-20 08:00AM  
Mar-05-20 04:05PM  
Mar-03-20 10:00AM  
Feb-25-20 10:27AM  
Feb-19-20 05:16PM  
Feb-12-20 09:18AM  
Feb-11-20 08:30AM  
Feb-07-20 08:00AM  
Feb-06-20 03:07PM  
Jan-30-20 08:13AM  
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing A'STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HARBERT MANAGEMENT CORP10% OwnerMar 16Sale4.65300,0001,393,9005,175,913Mar 17 05:28 PM
HARBERT MANAGEMENT CORP10% OwnerMar 15Sale4.83144,768698,8405,475,913Mar 17 05:28 PM